EP1631302A4 - Mittel zur behandlung von migräne - Google Patents

Mittel zur behandlung von migräne

Info

Publication number
EP1631302A4
EP1631302A4 EP04734446A EP04734446A EP1631302A4 EP 1631302 A4 EP1631302 A4 EP 1631302A4 EP 04734446 A EP04734446 A EP 04734446A EP 04734446 A EP04734446 A EP 04734446A EP 1631302 A4 EP1631302 A4 EP 1631302A4
Authority
EP
European Patent Office
Prior art keywords
migraine remedy
migraine
remedy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04734446A
Other languages
English (en)
French (fr)
Other versions
EP1631302A1 (de
Inventor
Larry Ellsworth Stenswick
Sirichai Chayasirisobhon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MigCo Ltd
Original Assignee
MigCo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MigCo Ltd filed Critical MigCo Ltd
Publication of EP1631302A1 publication Critical patent/EP1631302A1/de
Publication of EP1631302A4 publication Critical patent/EP1631302A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
EP04734446A 2003-05-23 2004-05-21 Mittel zur behandlung von migräne Withdrawn EP1631302A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ526098A NZ526098A (en) 2003-05-23 2003-05-23 Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine
PCT/NZ2004/000095 WO2004103411A1 (en) 2003-05-23 2004-05-21 Migraine remedy

Publications (2)

Publication Number Publication Date
EP1631302A1 EP1631302A1 (de) 2006-03-08
EP1631302A4 true EP1631302A4 (de) 2010-07-07

Family

ID=33476120

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04734446A Withdrawn EP1631302A4 (de) 2003-05-23 2004-05-21 Mittel zur behandlung von migräne

Country Status (8)

Country Link
EP (1) EP1631302A4 (de)
JP (1) JP2007501856A (de)
CN (1) CN1901928B (de)
AU (2) AU2004241889B2 (de)
CA (1) CA2526631A1 (de)
MX (1) MXPA05012636A (de)
NZ (1) NZ526098A (de)
WO (1) WO2004103411A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005005275A1 (de) * 2005-02-04 2006-08-10 Peter Heger Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Prävention und/oder Behandlung von Kopfschmerz und Migräne
JP2006298808A (ja) * 2005-04-19 2006-11-02 Hayashibara Biochem Lab Inc 痛覚刺激緩和剤
US20070059392A1 (en) * 2005-09-15 2007-03-15 Peter Rohdewald COX inhibitor
JP5430891B2 (ja) * 2007-10-04 2014-03-05 森永製菓株式会社 メラニン生成抑制剤
EP2902474A4 (de) * 2012-09-28 2016-03-16 Suntory Holdings Ltd Pflanzenextrakt ohne monomeres proanthocyanidin
CN116999563A (zh) * 2017-05-10 2023-11-07 艾克萨姆治疗公司 包含美洛昔康的药物组合物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360A (en) * 1985-04-09 1987-10-06 Societe Civile D'investigations Pharmacologiques D'aquitaine Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
WO1997044407A1 (en) * 1996-05-23 1997-11-27 Ian Alexander Gilmour Process for extraction of proanthocyanidins from botanical material
FR2775600A1 (fr) * 1998-03-05 1999-09-10 Ravi Shrivastava Nouvelle composition pharmaceutique pour le traitement des troubles d'origine neurologique
WO2002020028A2 (en) * 2000-09-06 2002-03-14 Braswell A Glenn Method and composition for enhancing vision
US6391310B1 (en) * 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5939076A (en) * 1997-11-12 1999-08-17 Allocca Techical, Inc. Composition and method for treating or alleviating migraine headaches
WO1999061028A1 (en) * 1998-05-27 1999-12-02 Gorbach Sherwood L Isoflavonoids for treatment and prevention of migraine headaches
IT1313862B1 (it) * 1999-11-11 2002-09-24 Solvay Cassone di estremita' di un elettrodializzatore, elettrodializzatoreche comprende tale cassone di estremita' e procedimento di
AU2003228603A1 (en) * 2002-04-22 2003-11-10 Rtc Research And Development, Llc. Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
JP2005534699A (ja) * 2002-08-06 2005-11-17 ザ キグリー コーポレーション 抗菌性組成物及びその使用方法
CA2407429C (en) * 2002-10-16 2007-02-20 Celt Corporation Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360A (en) * 1985-04-09 1987-10-06 Societe Civile D'investigations Pharmacologiques D'aquitaine Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US6391310B1 (en) * 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms
WO1997044407A1 (en) * 1996-05-23 1997-11-27 Ian Alexander Gilmour Process for extraction of proanthocyanidins from botanical material
FR2775600A1 (fr) * 1998-03-05 1999-09-10 Ravi Shrivastava Nouvelle composition pharmaceutique pour le traitement des troubles d'origine neurologique
WO2002020028A2 (en) * 2000-09-06 2002-03-14 Braswell A Glenn Method and composition for enhancing vision

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHAYASIRISOBHON ET AL: "PO29-FR-11 Use of a pine bark extract and vitamin C combination product as therapy for migraine", JOURNAL OF NEUROLOGICAL SCIENCES, ELSEVIER SCIENTIFIC PUBLISHING CO, AMSTERDAM, NL LNKD- DOI:10.1016/S0022-510X(09)71199-2, vol. 285, 1 October 2009 (2009-10-01), pages S315, XP026758276, ISSN: 0022-510X, [retrieved on 20091001] *
CHAYASIRISOBHON S: "Use of a pine bark extract and antioxidant vitamin combination product as therapy for migraine in patients refractory to pharmacologic medication", HEADACHE 200605 US LNKD- DOI:10.1111/J.1526-4610.2006.00454.X, vol. 46, no. 5, May 2006 (2006-05-01), pages 788 - 793, XP002582418 *
KOLODZIEJ H: "OLIGOMERIC FLAVAN-3-OLS FROM MEDICINAL WILLOW BARK", PHYTOCHEMISTRY (OXFORD), vol. 29, no. 3, 1990, pages 955 - 960, XP002582429, ISSN: 0031-9422 *
See also references of WO2004103411A1 *

Also Published As

Publication number Publication date
AU2004241889A1 (en) 2004-12-02
CN1901928B (zh) 2012-06-20
AU2004241889B2 (en) 2010-09-16
JP2007501856A (ja) 2007-02-01
MXPA05012636A (es) 2006-05-25
AU2010212521A1 (en) 2010-09-16
CN1901928A (zh) 2007-01-24
CA2526631A1 (en) 2004-12-02
EP1631302A1 (de) 2006-03-08
WO2004103411A1 (en) 2004-12-02
NZ526098A (en) 2005-10-28

Similar Documents

Publication Publication Date Title
TWI372050B (en) (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
DE602004023400D1 (en) Lies
DE502004011703D1 (en) N-heterocyclyl-phenylsubstituierte cyclische ketoenole
DE602004012071D1 (en) T-hilfe
AU314014S (en) Sink
DE502004009243D1 (en) Spirocyclische cyclohexan-derivate
AU155161S (en) Case
HK1145463A1 (en) Remedy
DE502004003476D1 (en) Standfuss
DE502004006683D1 (en) Injection-locked-oscillator-schaltkreis
DE502004011852D1 (en) Nspritzventil
DE502004004146D1 (en) Pyrazolverbindungen
DE112004002769D2 (en) Schienengeführtes transportsystem
DE602004012262D1 (en) Benzimidazolonverbindung
DE502004011343D1 (en) Rotorspinnmaschine
DE602004020525D1 (en) Imidazolderivate
DE502004012153D1 (en) Rotorspinnmaschine
EP1631302A4 (de) Mittel zur behandlung von migräne
DE10394343D2 (en) Berührungslose biometrische erkennung
AU155596S (en) Case
DE602004009041D1 (en) Hydroxytetrahydronaphthalenylharnstoffderivate
AU156879S (en) Sink
AU154774S (en) Sink
DE602004008281D1 (en) Avermectin-b1-monosaccharidderivative
AU156878S (en) Sink

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100604

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131203